DNMT1 and synovial sarcoma: To evaluate the nature of the phenotypes caused by DNMT1 removal in synovial sarcoma, we targeted DNMT1 in synovial sarcoma human cell lines using sgRNA or decitabine, a cytidine analog that cannot be methylated and, after incorporation into DNA, progressively dilutes methylation markers in the chromatin of proliferating cells.